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Participation in sports has emerged as a major facet of the 
present day life-style, involving a large proportion of the 
population. individuals of all ages and a wide variety of 
athletic endeavors, Much of this accelerated interest has 
been in competitive athletics, encompassing growing num•
bers of both youthful and older participants in organized 
individual and team sports, 
Parallel developments in cardiology and cardiovascular 
diagnosis during the last 10 years have provided us with a 
more refined and precise concept of the normal athlete heart. 
These advances also have enhanced our awareness of car•
diovascular disease in the athletic population and the po•
tentially detrimental effects (including premature sudden 
death) such disease may have on the individual athlete. 
Our heightened awareness of the problem of occult car•
diovascular disease in asymptomatic athletes was the major 
stimulus for the Symposium on the Athlete Heart in this 
issue of the Journal. In its entirety. this Symposium com•
prises six papers that discuss a wide spectrum of issues 
relevant to the athlete and cardiovascular disea~e. 
In the first paper. Maron (1) describes the morphologic 
features of the trained athlete heart that have been defined 
by echocardiography during the past decade. 
The next three papers (2-4) focus on the issue of sudden 
death in athletes. Maron et al. (2) provide a detailed de•
scription of the causes of sudden death in both youthful and 
older competitive athletes. Cobb and Weaver (3) review the 
risk of sudden death posed by exercise in subjects with 
underlying coronary heart disease; finally, Epstein and Ma•
ron (4) discuss the potential and the limitations of prepar•
ticipation screening studies for identifying the athlete at risk 
for sudden death. 
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In the fifth paper, Jeresaty (5) reviews the clinical defi•
nition, identification and prognostic implications of mitral 
valve prolapse in competitive athletes. Finally, Coelho et 
al. (6) describe a unique group of young athletes with symp•
tomatic tachyarrhythmias (with or without underlying car•
diovascular disease) who underwent electrophysiologic in•
vestigations. The findings of this study are relevant to the 
etiology, detection and clinical significance of exercise-in•
duced arrhythmias in athletes. 
The preceding issue of the Journal presented the 16th 
Bethesda Conference, "Cardiovascular abnormalities in the 
athlete: Recommendations regarding eligibility for compe•
tition." (7). This conference set standards governing par•
ticipation for competitive athletes with cardiovascular dis•
eases, and bears a direct and important relation to the present 
Symposium papers. 
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